If signed by President Trump in time to avoid a government shutdown, HR 7148 has potential to enforce significant change in the prescription drug supply chain.
Jesse Dresser, Esq
Advertisement
Jesse Dresser, Esq, partner in the Life Sciences Department and head of the Pharmacy Practice Group at Frier Levitt Attorneys at Law
Articles by Jesse Dresser, Esq
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
Evolving Regulatory Criteria Fuel Rx-to-OTC Rejections
2
Chronic Corticosteroid Use Harms Health, Increases Cost for Patients With Asthma
3
Pharmacy Law Lowdown: Legislative Shifts in 2026 PBM Reform
4
Vitamin D Shows Potential in Managing Metabolic Health for Diabetes
5